Launch of Next-Generation Clinical Trial Data Platform
Rutland, MA, Oct. 5, 2017- A brand new clinical trial database and collaborative platform was launched on October 3, with the aim of being the leading source for every clinical trial data need. PrimaryEndpoints.com will serve a broad audience of biotech investors, clinical researchers, patients, and their advocates.
The revolutionary website offers several features previously unavailable, including:
· Crowdsourced trial predictions.
· Data visualizations of clinical trial data.
· Trial events and results.
· Personalized watchlists.
· Access to biotech gurus.
· Trial-centric discussions.
The site’s sleek modern design showcases all of the data available on clinicaltrials.gov, but with more accessibility and ease of use.
The site was founded by Tim Burr, a tech entrepreneur and biotech investor. After much time toiling on clinicaltrials.gov, he knew there was a problem that needed solving. Tim says, ''we wanted to create a platform to ease the tedium and information overload users face when analyzing and sorting through clinical trial data. Given its importance, clinical trial data needs to be ultra-accessible for anyone that needs it.''
What to expect:
People who need to access clinical trial information have been asking for a tool to simplify the monitoring and analyzation of clinical trial data, and Primary Endpoints wants to be the answer. With Primary Endpoints:
· Trial tracking is made easy with customized visual timelines.
· Trial outcomes are predicted by biotech experts.
· Customized notifications of trial updates ensure you are among the first to know.
· Communication with biotech experts and gurus is made easy.
· Join discussion boards and engage with clinical and investing experts.
Be among the first.
Don't miss the opportunity to be among the first to discover this next generation platform for clinical trial data. Visit http://www.primaryendpoints.com/ to experience Primary Endpoints for yourself.
Contact:
Product Manager: Bhavana Singh
Scopic Software 12 Carly Circle Rutland MA 01543 US Phone: (855) 717-5586 (toll free)
Email: marketing@primaryendpoints.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
